Safety and Effectiveness of Edoxaban in Atrial Fibrillation Patients in Routine Clinical Practice: One-Year Follow-Up from the Global Noninterventional ETNA-AF Program

Non-vitamin K antagonist oral anticoagulants such as edoxaban are the standard of care for stroke prevention in patients with atrial fibrillation (AF). The Global Edoxaban Treatment in routiNe clinical prActice (ETNA)-AF program integrates prospective, observational, noninterventional regional studi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Med
Hlavní autoři: De Caterina, Raffaele, Kim, Young-Hoon, Koretsune, Yukihiro, Wang, Chun-Chieh, Yamashita, Takeshi, Chen, Cathy, Reimitz, Paul-Egbert, Unverdorben, Martin, Kirchhof, Paulus
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7913627/
https://ncbi.nlm.nih.gov/pubmed/33546442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10040573
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky